$XLV going to outperform $SPY (5/5)
Conviction: 5/5
Health Care (
XLV) is looking very attractive relative to S&P 500 (
SPY), just bounced off of long-term (2022) support on a relative basis.
RSI-M at oversold levels (obviously), while RSI-W seems to have put in a bullish divergence?
Let's see which channel wins, but I think long-term one is stronger.
Health Care (
XLV) is looking very attractive relative to S&P 500 (SPY), just bounced off of long-term (2022) support on a relative basis.RSI-M at oversold levels (obviously), while RSI-W seems to have put in a bullish divergence?
Let's see which channel wins, but I think long-term one is stronger.
Pernyataan Penyangkalan
Informasi dan publikasi tidak dimaksudkan untuk menjadi, dan bukan merupakan saran keuangan, investasi, perdagangan, atau rekomendasi lainnya yang diberikan atau didukung oleh TradingView. Baca selengkapnya di Persyaratan Penggunaan.